RNA-seq of A549 non-small cell lung cancer cells with fargesin treatment in vitro

In order to investigate the effects of fargesin (FGS) on A549 non-small cell lung cancer cells, RNA-seq were used to detect the potential anti-tumor mechanism of the treatment of FGS. The A549 non-small cell lung cancer cells were treated with or without FGS, then the total RNA of each group was harvested and performed with RNA-seq. Differentially expressed genes (DEGs) were calculated. After that GO enrichment including biological process, cellular component, and molecular function and KEGG pathway enrichment based on the above DEGs were analyzed.